Funding, News and Announcements

The Weston Brain Institute supports translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging. They are pleased to launch the Rapid Response: Canada 2018 program for Parkinson’s & Related Diseases.

Program Overview
Seed funding for novel, high-risk, high-reward translational research to accelerate the development of safe and effective treatments for neurodegenerative diseases of aging.

Funding
Up to $200,000 over up to 18 months

Eligibility
Principal applicants must be at or above the level of postdoctoral researcher at a CRA qualified institution located in Canada.

Disease Groups
This program is run through alternating calls that are disease focused.
Parkinson’s & Related Diseases:
PD, PSP, LBD, MSA, prodromes, and vascular contributions to the listed diseases
Alzheimer’s & Related Diseases:
AD, FTD, MCI prodromes, and vascular contributions to the listed diseases  

Current Call Important Dates
Parkinson & Related Disesases Program Information Session: October 10, 2017 at 1pm EDT (Register here)
Letter of Intent deadline: December 4, 2017 at 2pm ESTAnticipated Award: June 2018

APPLY HERE

New for 2018
The Institute has changed its definitions for tools and therapeutics.  Please visit our What We Fund page for more details.

For more information about the Rapid Response program, please see the Request for Applications (pdf) or visit our website.